Sonoma Pharmaceuticals, Inc.
SNOA
$2.79
$0.8040.20%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.16% | 40.06% | 19.75% | 6.13% | 25.21% |
| Total Depreciation and Amortization | -12.43% | 2.56% | 22.30% | 40.80% | 20.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.39% | -60.07% | -48.16% | -29.35% | 170.16% |
| Change in Net Operating Assets | 410.98% | 130.10% | 395.51% | 187.72% | -136.83% |
| Cash from Operations | 103.19% | 64.34% | 35.97% | 61.02% | 2.25% |
| Capital Expenditure | 85.71% | 87.92% | 98.10% | 93.68% | -48.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.11% | -91.33% | 36.36% | 36.36% | 212.50% |
| Cash from Investing | 85.29% | 79.10% | 103.97% | 99.22% | 56.96% |
| Total Debt Issued | -27.57% | -25.40% | -27.57% | -27.57% | 318.70% |
| Total Debt Repaid | 14.37% | 19.20% | 30.27% | 46.20% | 29.93% |
| Issuance of Common Stock | -19.94% | 42.99% | -11.65% | -37.97% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -94.38% | 300.00% | -68.75% | -- | 200.00% |
| Cash from Financing | -22.96% | 44.09% | -10.73% | -32.66% | 769.59% |
| Foreign Exchange rate Adjustments | -264.92% | -286.24% | -204.62% | -90.72% | 302.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,341.23% | 259.88% | 53.23% | 80.65% | 96.13% |
